Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) shares passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $9.16 and traded as high as $9.68. Cipher Pharmaceuticals shares last traded at $9.64, with a volume of 1,484 shares trading hands.
Cipher Pharmaceuticals Stock Down 2.6%
The firm’s fifty day moving average is $9.16 and its 200-day moving average is $9.28.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.
See Also
- Five stocks we like better than Cipher Pharmaceuticals
- How to buy stock: A step-by-step guide for beginners
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- What is the S&P/TSX Index?
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- How to Calculate Stock Profit
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
